Measurement instruments to assess basic functional mobility in Parkinson's Disease: A systematic review of clinimetric properties and feasibility for use in clinical practice
Measurement instruments to assess basic functional mobility in Parkinson's Disease: A systematic review of clinimetric properties and feasibility for use in clinical practice
复制标题
评估帕金森病基本功能活动能力的测量仪器
DOI:
10.11336/jjcrs.14.16
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Ariko Yamamoto
中科院分区:
文献类型:
--
作者:
Seira Taniguchi;Ariko Yamamoto
Taniguchi S, Yamamoto A. Measurement instruments to assess basic functional mobility in Parkinson’s Disease: A systematic review of clinimetric properties and feasibility for use in clinical practice. Jpn J Compr Rehabil Sci 2023; 14: 16‒25.ObjectiveTo systematically review the evaluation of clinimetric properties and feasibility of the “Modified Parkinson Activity Scale (M-PAS)” and the “Lindop Parkinson’s Disease Mobility Assessment (LPA),” which are Parkinson’s Disease (PD)-specific measurement instruments to assess basic functional mobility, and to discuss their considerations for use in clinical practice.MethodsA systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A risk of bias assessment was also performed.ResultsEleven studies were included: five studies used M-PAS (45%), five studies used LPA (45%), and one study used M-PAS and LPA (13%). The risk of bias was low for all evaluated studies.ConclusionM-PAS and LPA showed adequate reliability, validity, and responsiveness in detecting intervention changes. M-PAS has more detailed qualitative scoring options, a lack of ceiling effect, and can be used by a non-expert in PD. In contrast, the drawback of M-PAS is that it is timeconsuming to apply in everyday clinical practice. On the other hand, LPA with greater simplicity may lead to lower burdens for both patients and raters in situations with strict time limitations. Further research is required to identify new resources.